In this review, we have highlighted the preclinical evidence that IRs on the NK cell such as KIRs, NKG2A, TIGIT, TIM-3, PD-1, and LAG-3 may impact MM biology and response to treatments. The gene discussed is KLRC1; the disease is Miyoshi myopathy.